StockData
NeoGenomics Inc logo

NeoGenomics Inc (NEO) stock

NEONasdaqServices-Testing LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/3023% below fair value
$15.29+0.04 (+0.26%)

Close on Nov 18, 2026Market cap $1.98BP/E –Yield –

NeoGenomics operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

NeoGenomics's operating income for the twelve months ending Sep 30, 2026 was -$49.37M. For fiscal 2025 it was -$115.88M. The highest annual figure on record is $13.01M in fiscal 2019.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$115.88M–
FY2024Dec 31, 2024-$92.11M–
FY2023Dec 31, 2023-$107.74M–
FY2022Dec 31, 2022-$157.62M–
FY2021Dec 31, 2021-$118.75M–
FY2020Dec 31, 2020-$13.99M-207.6%
FY2019Dec 31, 2019$13.01M+29.5%
FY2018Dec 31, 2018$10.04M+246.0%
FY2017Dec 31, 2017$2.90M+34.7%
FY2016Dec 31, 2016$2.16M–
FY2015Dec 31, 2015-$5.64M-354.1%
FY2014Dec 31, 2014$2.22M-30.1%
FY2013Dec 31, 2013$3.17M+162.1%
FY2012Dec 31, 2012$1.21M–
FY2011Dec 31, 2011-$409.00K–
FY2010Dec 31, 2010-$2.96M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$7.94M–
Q2 FY2026Jun 30, 2026-$9.77M–
Q1 FY2026Mar 31, 2026-$18.24M–
Q4 FY2025Dec 31, 2025-$13.41M–
Q3 FY2025Sep 30, 2025-$27.01M–
Q2 FY2025Jun 30, 2025-$47.63M–
Q1 FY2025Mar 31, 2025-$27.83M–
Q4 FY2024Dec 31, 2024-$18.40M–
Q3 FY2024Sep 30, 2024-$21.20M–
Q2 FY2024Jun 30, 2024-$21.94M–
Q1 FY2024Mar 31, 2024-$30.57M–
Q4 FY2023Dec 31, 2023-$18.57M–
Q3 FY2023Sep 30, 2023-$24.20M–
Q2 FY2023Jun 30, 2023-$29.89M–
Q1 FY2023Mar 31, 2023-$35.07M–
Q4 FY2022Dec 31, 2022-$26.38M–
Q3 FY2022Sep 30, 2022-$39.51M–
Q2 FY2022Jun 30, 2022-$39.70M–
Q1 FY2022Mar 31, 2022-$52.03M–
Q4 FY2021Dec 31, 2021-$41.57M-850.4%
Q3 FY2021Sep 30, 2021-$39.71M-950.6%
Q2 FY2021Jun 30, 2021-$22.37M–
Q1 FY2021Mar 31, 2021-$15.11M–
Q4 FY2020Dec 31, 2020$5.54M+138.6%
Q3 FY2020Sep 30, 2020$4.67M+27.6%
Q2 FY2020Jun 30, 2020-$18.91M-522.2%
Q1 FY2020Mar 31, 2020-$5.29M-307.7%
Q4 FY2019Dec 31, 2019$2.32M-17.7%
Q3 FY2019Sep 30, 2019$3.66M-6.7%
Q2 FY2019Jun 30, 2019$4.48M+464.0%
Q1 FY2019Mar 31, 2019$2.55M+1.7%
Q4 FY2018Dec 31, 2018$2.82M-23.8%
Q3 FY2018Sep 30, 2018$3.92M–
Q2 FY2018Jun 30, 2018$794.00K-56.9%
Q1 FY2018Mar 31, 2018$2.51M–
Q4 FY2017Dec 31, 2017$3.70M–
Q3 FY2017Sep 30, 2017-$2.06M–
Q2 FY2017Jun 30, 2017$1.84M–
Q1 FY2017Mar 31, 2017-$580.00K–
Q4 FY2016Dec 31, 2016-$3.35M–

More NeoGenomics figures

See a number that looks wrong?